185 related articles for article (PubMed ID: 37990495)
21. The use of miR122 and its target sequence in adeno-associated virus-mediated trichosanthin gene therapy.
Ran G; Feng XL; Xie YL; Zheng QY; Guo PP; Yang M; Feng YL; Ling C; Zhu LQ; Zhong C
J Integr Med; 2021 Nov; 19(6):515-525. PubMed ID: 34538767
[TBL] [Abstract][Full Text] [Related]
22. Production of Recombinant Adeno-associated Virus Vectors Using Suspension HEK293 Cells and Continuous Harvest of Vector From the Culture Media for GMP FIX and FLT1 Clinical Vector.
Grieger JC; Soltys SM; Samulski RJ
Mol Ther; 2016 Feb; 24(2):287-297. PubMed ID: 26437810
[TBL] [Abstract][Full Text] [Related]
23. [Preparation of a novel AAV-ITR gene expression mini vector in Sf9 insect cells via baculovirus].
Li T; Pan J; Qi J; Zhang C
Sheng Wu Gong Cheng Xue Bao; 2015 Aug; 31(8):1230-8. PubMed ID: 26762044
[TBL] [Abstract][Full Text] [Related]
24. Production of recombinant adeno-associated viral vectors using a baculovirus/insect cell suspension culture system: from shake flasks to a 20-L bioreactor.
Meghrous J; Aucoin MG; Jacob D; Chahal PS; Arcand N; Kamen AA
Biotechnol Prog; 2005; 21(1):154-60. PubMed ID: 15903253
[TBL] [Abstract][Full Text] [Related]
25. Efficient production of an avian adeno-associated virus vector using insect cell/baculovirus expression system.
Wang A; Wang Y; Wu S; Zuo W; Guo C; Hong W; Zhu S
J Virol Methods; 2017 Feb; 240():26-31. PubMed ID: 27867046
[TBL] [Abstract][Full Text] [Related]
26. Delivering Transgenic DNA Exceeding the Carrying Capacity of AAV Vectors.
Hirsch ML; Wolf SJ; Samulski RJ
Methods Mol Biol; 2016; 1382():21-39. PubMed ID: 26611576
[TBL] [Abstract][Full Text] [Related]
27. Recombinant AAV Production.
Joshi PRH; Venereo-Sanchez A
Methods Mol Biol; 2024; 2829():203-214. PubMed ID: 38951336
[TBL] [Abstract][Full Text] [Related]
28. Efficient production of dual recombinant adeno-associated viral vectors for factor VIII delivery.
Wang Q; Dong B; Firrman J; Roberts S; Moore AR; Cao W; Diao Y; Kapranov P; Xu R; Xiao W
Hum Gene Ther Methods; 2014 Aug; 25(4):261-8. PubMed ID: 25093498
[TBL] [Abstract][Full Text] [Related]
29. High throughput production, screening and analysis of adeno-associated viral vectors.
Drittanti L; Rivet C; Manceau P; Danos O; Vega M
Gene Ther; 2000 Jun; 7(11):924-9. PubMed ID: 10849551
[TBL] [Abstract][Full Text] [Related]
30. Optimization of transfection mediated by calcium phosphate for plasmid rAAV-LacZ (recombinant adeno-associated virus-beta-galactosidase reporter gene) production in suspension-cultured HEK-293 (human embryonic kidney 293) cells.
Feng L; Guo M; Zhang S; Chu J; Zhuang Y; Zhang S
Biotechnol Appl Biochem; 2007 Feb; 46(Pt 2):127-35. PubMed ID: 17052245
[TBL] [Abstract][Full Text] [Related]
31. rAAV immunogenicity, toxicity, and durability in 255 clinical trials: A meta-analysis.
Shen W; Liu S; Ou L
Front Immunol; 2022; 13():1001263. PubMed ID: 36389770
[TBL] [Abstract][Full Text] [Related]
32. Construction of an rAAV Producer Cell Line through Synthetic Biology.
Lee Z; Lu M; Irfanullah E; Soukup M; Hu WS
ACS Synth Biol; 2022 Oct; 11(10):3285-3295. PubMed ID: 36219557
[TBL] [Abstract][Full Text] [Related]
33. Genetics instability of wtAAV2 genome and AAV promoter activities in the Baculovirus/Sf9 cells system.
Savy A; Kaikkonen MU; Léger A; Dickx Y; Galibert L; Merten OW
PLoS One; 2018; 13(7):e0199866. PubMed ID: 29975713
[TBL] [Abstract][Full Text] [Related]
34. A simplified baculovirus-AAV expression vector system coupled with one-step affinity purification yields high-titer rAAV stocks from insect cells.
Smith RH; Levy JR; Kotin RM
Mol Ther; 2009 Nov; 17(11):1888-96. PubMed ID: 19532142
[TBL] [Abstract][Full Text] [Related]
35. Impact of dual-baculovirus infection on the Sf9 insect cell transcriptome during rAAV production using single-cell RNA-seq.
Virgolini N; Silvano M; Hagan R; Correia R; Alves PM; Clarke C; Roldão A; Isidro IA
Biotechnol Bioeng; 2023 Sep; 120(9):2588-2600. PubMed ID: 36919374
[TBL] [Abstract][Full Text] [Related]
36. Towards a scalable bioprocess for rAAV production using a HeLa stable cell line.
Escandell J; Moura F; Carvalho SB; Silva RJS; Correia R; Roldão A; Gomes-Alves P; Alves PM
Biotechnol Bioeng; 2023 Sep; 120(9):2578-2587. PubMed ID: 37027346
[TBL] [Abstract][Full Text] [Related]
37. Comprehensive mRNA-sequencing-based characterization of three HEK-293 cell lines during an rAAV production process for gene therapy applications.
Pistek M; Kahlig CI; Hackl M; Unterthurner S; Kraus B; Grabherr R; Grillari J; Hernandez Bort JA
Biotechnol J; 2023 Aug; 18(8):e2200513. PubMed ID: 37191240
[TBL] [Abstract][Full Text] [Related]
38. A helper virus-free packaging system for recombinant adeno-associated virus vectors.
Collaco RF; Cao X; Trempe JP
Gene; 1999 Oct; 238(2):397-405. PubMed ID: 10570967
[TBL] [Abstract][Full Text] [Related]
39. Scalable production of adeno-associated virus type 2 vectors via suspension transfection.
Park JY; Lim BP; Lee K; Kim YG; Jo EC
Biotechnol Bioeng; 2006 Jun; 94(3):416-30. PubMed ID: 16622883
[TBL] [Abstract][Full Text] [Related]
40. Factors influencing recombinant adeno-associated virus production.
Salvetti A; Orève S; Chadeuf G; Favre D; Cherel Y; Champion-Arnaud P; David-Ameline J; Moullier P
Hum Gene Ther; 1998 Mar; 9(5):695-706. PubMed ID: 9551617
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
